Subline
ActiveSummary
Subline has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €208,044 and a net result of €45,512. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 91% of 1,583 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Equity above €200,000equity €208,044 ▲28%
A profit in every financial year since 2020 builds equity to €208,044.
07-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Liquidity more than doubledcurrent ratio 21.67
Current ratio from 7.39 to 21.67; short-term debt falls from €21,385 to €7,609.
31-12
Financial
Equity above €150,000equity €162,533 ▲13.1%
A profit in every financial year since 2020 builds equity to €162,533.
04-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Liquidity more than doubledcurrent ratio 7.39
Current ratio from 3.16 to 7.39; short-term debt falls from €46,641 to €21,385.
22-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 22 days late
2022
31-12
Financial
Equity above €100,000equity €116,972 ▲20.6%
A profit in every financial year since 2020 builds equity to €116,972.
29-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Highest result from 2020 to 2025net €74,478 ▲635%
Operating result €104,104, net result €74,478, both a record.
30-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.